Malaria Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

COVID-19 Transmission and Morbidity in Malawi
Conditions:   SARS CoV 2 Infection;   SARS CoV 2 Vaccination Intervention:   Sponsors:   Boston University;   National Institute of Allergy and Infectious Diseases (NIAID);   Malaria Alert Center, Kamuzu University of Health Sciences;   Burnet Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials

COVID Transmission and Morbidity in Malawi
Conditions:   SARS CoV 2 Infection;   SARS CoV 2 Vaccination Intervention:   Sponsors:   Boston University;   National Institute of Allergy and Infectious Diseases (NIAID);   Malaria Alert Center, Kamuzu University of Health Sciences;   Burnet Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials

Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults
Condition:   Malaria Intervention:   Drug: Pvs230D1-EPA/Matrix-M Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials